Home / Products / Cancer (Tumor) Cell Lines / LNCaP C4-2B
LNCaP C4-2B
Datasheet Protocol

LNCaP C4-2B

Cat. No. ARC0452
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Prostate

Growth Properties:

Adherent

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

LNCaP C4-2B is a cancer cell line of prostate carcinoma, isolated from metastatic; left supraclavicular lymph node.

Recommended Products

IREB2 Knockout K562 Polyclonal Cells IREB2 Knockout K562 Polyclonal Cells Cat. No. ARG20677 MTX3 Knockout jurkat Polyclonal Cells MTX3 Knockout jurkat Polyclonal Cells Cat. No. ARG12935 ETFB Knockout A549 Polyclonal Cells ETFB Knockout A549 Polyclonal Cells Cat. No. ARG10895 ALPP Knockout 143B Polyclonal Cells ALPP Knockout 143B Polyclonal Cells Cat. No. ARG35004 ARHGEF12 Knockout AGS Polyclonal Cells ARHGEF12 Knockout AGS Polyclonal Cells Cat. No. ARG26636 MIER2 Knockout Raji Polyclonal Cells MIER2 Knockout Raji Polyclonal Cells Cat. No. ARG1790
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Prostate
Disease:
Carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
50 years
Sex of Donor:
Male
Derived From Site:
Metastatic; Left supraclavicular lymph node
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

ARL2BP Knockout K562 Polyclonal Cells

ARL2BP Knockout K562 Polyclonal Cells

Cat. No. ARG20213
 EPN1 Knockout NCI-H1975 Polyclonal Cells

EPN1 Knockout NCI-H1975 Polyclonal Cells

Cat. No. ARG17322
 GLB1 Knockout Hela Polyclonal Cells

GLB1 Knockout Hela Polyclonal Cells

Cat. No. ARG7925
 ATP11C Knockout HT29 Polyclonal Cells

ATP11C Knockout HT29 Polyclonal Cells

Cat. No. ARG33085
 B2M Knockout Hepa 1-6 Polyclonal Cells

B2M Knockout Hepa 1-6 Polyclonal Cells

Cat. No. ARG37109
 Human Schwann Cell Medium

Human Schwann Cell Medium

Cat. No. ARM0103